# Comprehensive Genomic Profiling of Colorectal Cancer Patients With Isolated Liver Metastases to Understand Response & Resistance to Cancer Therapy

> **NCT03364621** · — · ACTIVE_NOT_RECRUITING · sponsor: **University Health Network, Toronto** · enrollment: 17 (actual)

## Conditions studied

- Colorectal Cancer
- Colorectal Cancer Metastatic
- Hepatic Metastases

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03364621
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-08-29
- **Primary completion:** 2026-06-29
- **Final completion:** 2026-06-29
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2025-07-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03364621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03364621, "Comprehensive Genomic Profiling of Colorectal Cancer Patients With Isolated Liver Metastases to Understand Response & Resistance to Cancer Therapy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03364621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*